Who Buys Glimepiride from India — 535 Importers Behind a $76.3M Market
India's glimepiride import market is served by 535 active buyers who collectively imported $76.3M across 3,159 shipments. EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES) leads with a 1.7% market share, followed by EVERSANA LIFE SCIENCE SERVICES LLC and MEIJI SEIKA PHARMATECH CO., LTD. The top 5 buyers together control 6.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Glimepiride Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES) is the leading glimepiride importer from India, holding a 1.7% share of the $76.3M market across 3,159 shipments from 535 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES), EVERSANA LIFE SCIENCE SERVICES LLC (UNITED STATES), MEIJI SEIKA PHARMATECH CO., LTD (JAPAN), MEIJI SEIKA PHARMATECH CO LIMITED (JAPAN), AJANTA PHARMA PHILIPPINES INC (PHILIPPINES) — collectively control 6.1% of total import value.
Top Glimepiride Buyers & Importers
Ranked by import value · 535 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES, LLCUNITED STATES GLIMEPIRIDE TABLETS 4MG, PACK OF 500GLIMEPIRIDE TABLETS 2MG, PACK OF 500GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 | $1.3M | 5 | 1.7% |
| 2 | EVERSANA LIFE SCIENCE SERVICES LLCUNITED STATES GLIMEPIRIDE TABLETS 4MG, PACK OF 500GLIMEPIRIDE TABLETS 2MG, PACK OF 500GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 | $905.2K | 5 | 1.2% |
| 3 | MEIJI SEIKA PHARMATECH CO., LTDJAPAN GLIMEPIRIDE 1MG TABLETS PO NO.MM-158-22GLIMEPIRIDE 0.5MG TABLETS PO NO.MM-158-GLIMEPIRIDE 1MG TABLETS, PO NO.MM-152, P | $840.5K | 5 | 1.1% |
| 4 | MEIJI SEIKA PHARMATECH CO LIMITEDJAPAN GLIMEPIRIDE 1MG TABLETS PO NO.MM-158-22GLIMEPIRIDE 0.5MG TABLETS PO NO.MM-158-GLIMEPIRIDE 1MG TABLETS, PO NO.MM-152, P | $818.7K | 5 | 1.1% |
| 5 | AJANTA PHARMA PHILIPPINES INCPHILIPPINES LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HLUPIMET GLIMEPIRIDE 2MG AND METFORMIN HGLIMEPIRIDE + METFORMIN HYDROC | $795.0K | 5 | 1.0% |
| 6 | APL SWIFT SERVICES (MALTA) LTD.,MALTA GLIMEPRIDE TABLETS 3MG(GLIMEPIRIDE AUROBGLIMEPRIDE TABLETS 2MG(GLIMEPIRIDE AUROBGLIMEPRIDE TABLETS 4MG(GLIMEPIRIDE AUROB | $780.5K | 5 | 1.0% |
| 7 | AMERISOURCE HEALTH SERVICESUNITED STATES GLIMEPIRIDE TABLETS 4MG, PACK OF 500GLIMEPIRIDE TABLETS 2MG, PACK OF 500GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 | $704.6K | 5 | 0.9% |
| 8 | DR REDDYS LABORATORIES INCUNITED STATES GLIMEPIRIDE TABLETS 4MG, PACK OF 500GLIMEPIRIDE TABLETS 2MG, PACK OF 500GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 | $696.6K | 5 | 0.9% |
| 9 | XX REXXYS XXBORXXORIXX INXXUNITED STATES GLIMEPIRIDE TABLETS 4MG, PACK OF 500GLIMEPIRIDE TABLETS 2MG, PACK OF 500GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 | $668.4K | 5 | 0.9% |
| 10 | I.E. MEDICA INC.PHILIPPINES LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HLUPIMET GLIMEPIRIDE 2MG AND METFORMIN HGLIMEPIRIDE + METFORMIN HYDROC | $574.6K | 5 | 0.8% |
| 11 | MAXXCARE COMPANY LIMITEDVIETNAM PERGLIM M-2PERGLIM M -2 NOSPERGLIM M -1 AS PER INVNOS | $476.0K | 5 | 0.6% |
| 12 | BROWN AND BURK PHILIPPINES INCPHILIPPINES LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HLUPIMET GLIMEPIRIDE 2MG AND METFORMIN HGLIMEPIRIDE + METFORMIN HYDROC | $460.0K | 5 | 0.6% |
| 13 | MAXXCARE COMPANY LIMITED.VIETNAM PERGLIM M-2PERGLIM M -2 NOSPERGLIM M -1 AS PER INVNOS | $452.0K | 5 | 0.6% |
| 14 | ZENTIVA SA ROMANIAROMANIA | $443.2K | 5 | 0.6% |
| 15 | HEALOL PHARMACEUTICALS SDN. BHD.,MALAYSIA LUPIMET (GLIMEPIRIDE 2MG AND METFORMIN HLUPIMET GLIMEPIRIDE 2MG AND METFORMIN HGLIMEPIRIDE + METFORMIN HYDROC | $375.5K | 5 | 0.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Glimepiride — and from which countries?
Flow of Glimepiride exports from India: each country's share and the named importers behind the numbers
Glimepiride — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $51.2M through 122 shipments. This represents a market share of 67.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES, LLC - $1.3M (2.5% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES LLC - $905.2K (1.8% of country's total business)
• AMERISOURCE HEALTH SERVICES - $704.6K (1.4% of country's total business)
• DR REDDYS LABORATORIES INC - $696.6K (1.4% of country's total business)
• XX REXXYS XXBORXXORIXX INXX - $668.4K (1.3% of country's total business)
• Rest of United States's importers - $46.9M (91.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $419.7K, indicating premium pricing strategy compared to the market average of $24.2K.
United States is a key market for Glimepiride imports, representing 67.1% of total trade value.
2South Africa
South Africa emerges as the second largest importing country, achieving a total trade value of $3.7M through 0 shipments. This represents a market share of 4.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $3.7M, indicating premium pricing strategy compared to the market average of $24.2K.
South Africa is a key market for Glimepiride imports, representing 4.8% of total trade value.
3Philippines
Philippines emerges as the third largest importing country, achieving a total trade value of $3.4M through 68 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• AJANTA PHARMA PHILIPPINES INC - $795.0K (23.3% of country's total business)
• I.E. MEDICA INC. - $574.6K (16.9% of country's total business)
• BROWN AND BURK PHILIPPINES INC - $460.0K (13.5% of country's total business)
• AMBICA INTERNATIONAL CORPORATION - $337.5K (9.9% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $50.1K, indicating premium pricing strategy compared to the market average of $24.2K.
Philippines is a key market for Glimepiride imports, representing 4.5% of total trade value.
4Japan
Japan emerges as the fourth largest importing country, achieving a total trade value of $2.3M through 28 shipments. This represents a market share of 3.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Japan has a diverse importer base, with their top importers including:
• MEIJI SEIKA PHARMATECH CO., LTD - $840.5K (36.8% of country's total business)
• MEIJI SEIKA PHARMATECH CO LIMITED - $818.7K (35.9% of country's total business)
Key Insight: Japan demonstrates strong market positioning with an average shipment value of $81.5K, indicating premium pricing strategy compared to the market average of $24.2K.
Japan is a key market for Glimepiride imports, representing 3.0% of total trade value.
5Cyprus
Cyprus emerges as the fifth largest importing country, achieving a total trade value of $1.4M through 0 shipments. This represents a market share of 1.8% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Cyprus demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $24.2K.
Cyprus is a key market for Glimepiride imports, representing 1.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Glimepiride buyer market intelligence
1Buyer Segment Analysis
The 535 buyers of Glimepiride imported from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES, LLC and AMERISOURCE HEALTH SERVICES in the United States fall into this category. These organizations purchase large quantities to supply pharmacies, hospitals, and healthcare providers. Their buying behavior is characterized by bulk orders and a high repeat purchase rate, ensuring a consistent supply chain.
2. Contract Manufacturers: Companies such as DR. REDDY'S LABORATORIES INC in the United States procure Glimepiride for formulation into finished pharmaceutical products. Their procurement patterns are aligned with production schedules and market demand forecasts, often involving substantial volumes to achieve economies of scale.
3. Hospital Groups: Entities like I.E. MEDICA INC. in the Philippines represent hospital groups that import Glimepiride directly for patient care. Their purchasing behavior is driven by patient needs, leading to regular, moderate-sized orders to maintain adequate stock levels.
4. Retail Chains: Companies such as AJANTA PHARMA PHILIPPINES INC in the Philippines import Glimepiride to supply their network of retail pharmacies. Their order patterns are influenced by consumer demand, resulting in frequent, smaller orders to ensure product availability across outlets.
5. Re-exporters: Firms like APL SWIFT SERVICES (MALTA) LTD. in Malta act as intermediaries, importing Glimepiride for redistribution to other markets. Their buying behavior involves large, periodic orders based on the demand in their target export destinations.
6. Government Procurement Agencies: While not explicitly listed among the top buyers, government agencies in various countries procure Glimepiride through tenders to supply public healthcare facilities. Their purchasing patterns are typically characterized by large, infrequent orders aligned with budget cycles and public health initiatives.
Country-Specific Import Regulations
TransData Nexus Glimepiride buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process for Glimepiride: Importers must ensure that Glimepiride is FDA-approved. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the reference listed drug.
3. Estimated Timeline for Registration: The ANDA review process typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.
South Africa
1. Drug Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
2. Import Registration Process for Glimepiride: Importers must register the product with SAHPRA, providing comprehensive data on quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take approximately 24 months, depending on the complexity of the application and SAHPRA's review capacity.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are subject to a 0% import duty in South Africa.
Philippines
1. Drug Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
2. Import Registration Process for Glimepiride: Importers must obtain a Certificate of Product Registration (CPR) from FDA Philippines, submitting dossiers that include product information, manufacturing details, and clinical data.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the submission and FDA's evaluation process.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally exempt from import duties in the Philippines.
Japan
1. Drug Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).
2. Import Registration Process for Glimepiride: Importers must obtain approval from the PMDA, involving the submission of a New Drug Application (NDA) or a Foreign Manufacturer Accreditation, depending on the product's status.
3. Estimated Timeline for Registration: The approval process can take 12 to 18 months, influenced by the complexity of the application and PMDA's review schedule.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are subject to a 0% import duty in Japan.
Cyprus
1. Drug Regulatory Authority: Pharmaceutical Services of the Ministry of Health, Cyprus.
2. Import Registration Process for Glimepiride: Importers must register the product with the Pharmaceutical Services, providing documentation on quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process typically takes 12 to 24 months, depending on the completeness of the application and the review process.
4. Import Tariff/Duty for HS 30049099: As a member of the European Union, Cyprus applies the EU's Common External Tariff, which generally imposes a 0% duty on pharmaceutical products under HS code 30049099.
Demand Drivers & Market Opportunity
TransData Nexus Glimepiride buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Glimepiride in importing countries is primarily driven by the increasing prevalence of type 2 diabetes mellitus (T2DM). According to the World Health Organization (WHO), the global prevalence of diabetes among adults has risen from 4.7% in 1980 to 8.5% in 2014, with a significant portion attributed to T2DM. This upward trend underscores the growing need for effective oral antidiabetic agents like Glimepiride.
Government healthcare programs and the expansion of universal health coverage also play pivotal roles in driving demand. Many countries have included Glimepiride in their national essential medicines lists, aligning with the WHO's Essential Medicines List, which recommends Glimepiride for the management of T2DM. This inclusion facilitates procurement through government tenders and bulk purchasing agreements, ensuring widespread availability and affordability. The presence of 535 buyers across 94 countries, as per our data, reflects the extensive global reach and market opportunity for Glimepiride.
Common Questions — Glimepiride Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest glimepiride buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES, LLC (UNITED STATES) leads with $1.3M in imports and a 1.7% market share — the highest of any single glimepiride importer. EVERSANA LIFE SCIENCE SERVICES LLC (UNITED STATES) and MEIJI SEIKA PHARMATECH CO., LTD (JAPAN) are the next largest buyers.
QHow many companies buy glimepiride from India?
There are 535 active glimepiride buyers importing from India, with a combined market of $76.3M across 3,159 shipments to 94 countries. The top 5 buyers hold 6.1% of total import value, while the remaining 530 buyers handle the other 93.9%.
QWhich countries import the most glimepiride from India?
The top importing countries for glimepiride from India are United States (67.1%), South Africa (4.8%), Philippines (4.5%), Japan (3.0%), Cyprus (1.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of glimepiride, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for glimepiride from India?
The average import transaction value for glimepiride from India is $24.2K, with an average unit price of $281.82 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Glimepiride buyer market intelligence
1Buyer Segment Analysis
The 535 buyers of Glimepiride imported from India can be categorized into several segments:
1. Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES, LLC and AMERISOURCE HEALTH SERVICES in the United States fall into this category. These organizations purchase large quantities to supply pharmacies, hospitals, and healthcare providers. Their buying behavior is characterized by bulk orders and a high repeat purchase rate, ensuring a consistent supply chain.
2. Contract Manufacturers: Companies such as DR. REDDY'S LABORATORIES INC in the United States procure Glimepiride for formulation into finished pharmaceutical products. Their procurement patterns are aligned with production schedules and market demand forecasts, often involving substantial volumes to achieve economies of scale.
3. Hospital Groups: Entities like I.E. MEDICA INC. in the Philippines represent hospital groups that import Glimepiride directly for patient care. Their purchasing behavior is driven by patient needs, leading to regular, moderate-sized orders to maintain adequate stock levels.
4. Retail Chains: Companies such as AJANTA PHARMA PHILIPPINES INC in the Philippines import Glimepiride to supply their network of retail pharmacies. Their order patterns are influenced by consumer demand, resulting in frequent, smaller orders to ensure product availability across outlets.
5. Re-exporters: Firms like APL SWIFT SERVICES (MALTA) LTD. in Malta act as intermediaries, importing Glimepiride for redistribution to other markets. Their buying behavior involves large, periodic orders based on the demand in their target export destinations.
6. Government Procurement Agencies: While not explicitly listed among the top buyers, government agencies in various countries procure Glimepiride through tenders to supply public healthcare facilities. Their purchasing patterns are typically characterized by large, infrequent orders aligned with budget cycles and public health initiatives.
Country-Specific Import Regulations
TransData Nexus Glimepiride buyer market intelligence
1Country-Specific Import Regulations
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process for Glimepiride: Importers must ensure that Glimepiride is FDA-approved. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the reference listed drug.
3. Estimated Timeline for Registration: The ANDA review process typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.
South Africa
1. Drug Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
2. Import Registration Process for Glimepiride: Importers must register the product with SAHPRA, providing comprehensive data on quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process can take approximately 24 months, depending on the complexity of the application and SAHPRA's review capacity.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are subject to a 0% import duty in South Africa.
Philippines
1. Drug Regulatory Authority: Food and Drug Administration Philippines (FDA Philippines).
2. Import Registration Process for Glimepiride: Importers must obtain a Certificate of Product Registration (CPR) from FDA Philippines, submitting dossiers that include product information, manufacturing details, and clinical data.
3. Estimated Timeline for Registration: The registration process typically takes 6 to 12 months, depending on the completeness of the submission and FDA's evaluation process.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally exempt from import duties in the Philippines.
Japan
1. Drug Regulatory Authority: Pharmaceuticals and Medical Devices Agency (PMDA).
2. Import Registration Process for Glimepiride: Importers must obtain approval from the PMDA, involving the submission of a New Drug Application (NDA) or a Foreign Manufacturer Accreditation, depending on the product's status.
3. Estimated Timeline for Registration: The approval process can take 12 to 18 months, influenced by the complexity of the application and PMDA's review schedule.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are subject to a 0% import duty in Japan.
Cyprus
1. Drug Regulatory Authority: Pharmaceutical Services of the Ministry of Health, Cyprus.
2. Import Registration Process for Glimepiride: Importers must register the product with the Pharmaceutical Services, providing documentation on quality, safety, and efficacy.
3. Estimated Timeline for Registration: The registration process typically takes 12 to 24 months, depending on the completeness of the application and the review process.
4. Import Tariff/Duty for HS 30049099: As a member of the European Union, Cyprus applies the EU's Common External Tariff, which generally imposes a 0% duty on pharmaceutical products under HS code 30049099.
Demand Drivers & Market Opportunity
TransData Nexus Glimepiride buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Glimepiride in importing countries is primarily driven by the increasing prevalence of type 2 diabetes mellitus (T2DM). According to the World Health Organization (WHO), the global prevalence of diabetes among adults has risen from 4.7% in 1980 to 8.5% in 2014, with a significant portion attributed to T2DM. This upward trend underscores the growing need for effective oral antidiabetic agents like Glimepiride.
Government healthcare programs and the expansion of universal health coverage also play pivotal roles in driving demand. Many countries have included Glimepiride in their national essential medicines lists, aligning with the WHO's Essential Medicines List, which recommends Glimepiride for the management of T2DM. This inclusion facilitates procurement through government tenders and bulk purchasing agreements, ensuring widespread availability and affordability. The presence of 535 buyers across 94 countries, as per our data, reflects the extensive global reach and market opportunity for Glimepiride.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 535 global importers of Glimepiride identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,159 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 94 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,159 Verified Shipments
535 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists